Published in Biochim Biophys Acta on October 08, 2015
Inflammation and cancer. Nature (2002) 53.78
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer (2012) 24.94
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 13.44
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet (2010) 13.13
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 9.22
Oncogene-induced senescence as an initial barrier in lymphoma development. Nature (2005) 9.16
The regulation of INK4/ARF in cancer and aging. Cell (2006) 8.75
Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell (2012) 8.71
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol (2007) 8.31
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A (2001) 7.93
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 7.74
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature (2013) 7.51
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
Four faces of cellular senescence. J Cell Biol (2011) 6.86
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell (2008) 6.84
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell (2002) 6.76
Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell (2004) 6.48
Senescence in tumours: evidence from mice and humans. Nat Rev Cancer (2010) 6.34
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature (2011) 6.14
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol (2001) 4.81
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev (1994) 4.64
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci (2005) 3.96
Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science (2013) 3.91
Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell (2010) 3.81
The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol (2000) 3.79
Reactive stroma in prostate cancer progression. J Urol (2001) 3.21
Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev (2006) 3.14
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res (2006) 3.07
CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. Clin Cancer Res (2013) 3.02
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem (2006) 3.00
A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98
DNA damage-mediated induction of a chemoresistant niche. Cell (2010) 2.94
Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res (2007) 2.94
DNA damage response and cellular senescence in tissues of aging mice. Aging Cell (2009) 2.91
An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell (2014) 2.89
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol (2015) 2.85
Inflammation and the development of pancreatic cancer. Surg Oncol (2002) 2.83
Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A (2009) 2.82
Programmed cell senescence during mammalian embryonic development. Cell (2013) 2.78
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res (1999) 2.67
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J (2011) 2.61
Therapy-induced senescence in cancer. J Natl Cancer Inst (2010) 2.45
Non-cell-autonomous tumor suppression by p53. Cell (2013) 2.40
A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One (2010) 2.38
Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene (1999) 2.34
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci (2010) 2.34
Cancers complicating inflammatory bowel disease. N Engl J Med (2015) 2.33
Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell (2013) 2.33
Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev (2010) 2.32
N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther (1996) 2.24
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell (2012) 2.04
Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res (2006) 2.04
Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol (2001) 1.98
Inside and out: the activities of senescence in cancer. Nat Rev Cancer (2014) 1.96
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature (2014) 1.88
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol (2001) 1.88
Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res (1994) 1.86
Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol (1996) 1.78
Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci (1992) 1.78
FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease. Clin Cancer Res (2015) 1.53
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell (2004) 1.51
Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand (1999) 1.38
Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res (2009) 1.38
Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep (2014) 1.35
Cytokine expression and signaling in drug-induced cellular senescence. Oncogene (2009) 1.34
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med (2013) 1.34
Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. Cancer Res (2005) 1.28
p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discov (2014) 1.27
A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell (2013) 1.22
Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol (2013) 1.22
Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res (2012) 1.17
Senescence and the pro-tumorigenic stroma. Crit Rev Oncog (2013) 1.16
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol (1998) 1.15
Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp Gerontol (2006) 1.08
Case-control study of aspirin use and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2014) 1.00
Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer (2014) 0.97
Innate inflammation in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 0.96
Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol (2015) 0.94
Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. Int J Cancer (2008) 0.91
IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522). Semin Arthritis Rheum (2012) 0.90
Senescence: the good the bad and the dysfunctional. Curr Opin Genet Dev (2008) 0.88